Stocks in play: Bausch Health Companies Inc.

And its gastroenterology business, Salix Pharmaceuticals,, one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, today introduced a collection of digital and social activations aimed at helping adult patients with opioid-induced constipation, irritable bowel syndrome with constipation and chronic idiopathic constipation. Launched during Constipation Awareness Month in December, the digital and social activations are designed to help patients with constipation and their caregivers identify symptoms and potential causes of constipation and find appropriate treatment options. Bausch Health Companies Inc. shares T.BHC are trading down $0.15 at $29.89.

Read:

• Plant-Based Meats Market Projected to Hit $162 Billion by 2030, as New Products Launch

• Innovations in Plant-Based Protein Products Supplying the Food Industry’s Strongest Trends

• Dogecoin Set to Deliver Long Term, as Major Businesses Make Moves to Accept it as Payment

• Crypto Miners Making Gains on Rising Waves for Bitcoin, Ethereum, Dogecoin and More

• Hedge-Like Properties of Bitcoin and Other Digital Currencies are Driving Crypto Mining Stocks Up